Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship
1Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Aging accelerates liver disease development, including metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH). Understanding this interplay is key to developing future treatments for liver aging and disease.
Area of Science:
- Gerontology
- Hepatology
- Cellular Biology
Background:
- Aging is increasingly linked to chronic liver diseases like MASLD and MASH.
- The aging process impairs liver functions, including metabolism, detoxification, and immunity, raising disease risk.
- Cellular senescence in hepatocytes, endothelial cells, stellate cells, and Kupffer cells contributes to liver aging.
Purpose of the Study:
- To review the complex interplay between aging and MASLD/MASH.
- To elucidate how aging and liver disease exacerbate each other.
- To discuss potential strategies for mitigating aging and treating liver diseases.
Main Methods:
- Literature review and synthesis of current research on aging and liver disease.
- Analysis of the mechanisms linking cellular senescence to liver dysfunction.
- Examination of therapeutic approaches targeting aging and liver pathologies.
Main Results:
- Aging significantly contributes to the pathogenesis and progression of MASLD and MASH.
- Liver disease accelerates the aging phenotype and cellular senescence.
- A bidirectional relationship exists where aging worsens liver disease, and liver disease promotes aging.
Conclusions:
- The aging-liver disease axis presents a critical challenge in hepatology.
- Targeting cellular senescence and aging pathways may offer novel therapeutic avenues for MASLD/MASH.
- Further research is needed to develop effective interventions for age-related liver conditions.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cholesterol: Significance and Regulation
Considering cholesterol and...

